United States Hemophilia Treatment Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 Hemophilia Treatment Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Hemophilia Treatment Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Hemophilia Treatment Overall Market Size
2.1 United States Hemophilia Treatment Market Size: 2021 VS 2027
2.2 United States Hemophilia Treatment Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Hemophilia Treatment Players in United States Market
3.2 Top United States Hemophilia Treatment Companies Ranked by Revenue
3.3 United States Hemophilia Treatment Revenue by Companies
3.4 Top 3 and Top 5 Hemophilia Treatment Companies in United States Market, by Revenue in 2020
3.5 Companies Hemophilia Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hemophilia Treatment Players in United States Market
3.6.1 List of Tier 1 Hemophilia Treatment Companies in United States
3.6.2 List of Tier 2 and Tier 3 Hemophilia Treatment Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Hemophilia Treatment Market Size Markets, 2021 & 2027
4.1.2 On-demand
4.1.3 Prophylaxis
4.2 By Type - United States Hemophilia Treatment Revenue & Forecasts
4.2.1 By Type - United States Hemophilia Treatment Revenue, 2016-2021
4.2.2 By Type - United States Hemophilia Treatment Revenue, 2022-2027
4.2.3 By Type - United States Hemophilia Treatment Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Hemophilia Treatment Market Size, 2021 & 2027
5.1.2 Replacement Therapy
5.1.3 ITI Therapy
5.1.4 Gene Therapy
5.2 By Application - United States Hemophilia Treatment Revenue & Forecasts
5.2.1 By Application - United States Hemophilia Treatment Revenue, 2016-2021
5.2.2 By Application - United States Hemophilia Treatment Revenue, 2022-2027
5.2.3 By Application - United States Hemophilia Treatment Revenue Market Share, 2016-2027
6 Hemophilia Treatment Companies Profiles
6.1 CSL Behring
6.1.1 CSL Behring Company Details
6.1.2 CSL Behring Business Overview
6.1.3 CSL Behring Hemophilia Treatment Introduction
6.1.4 CSL Behring Hemophilia Treatment Revenue in United States Market (2016-2021)
6.1.5 CSL Behring Recent Developments
6.2 Baxalta
6.2.1 Baxalta Company Details
6.2.2 Baxalta Business Overview
6.2.3 Baxalta Hemophilia Treatment Introduction
6.2.4 Baxalta Hemophilia Treatment Revenue in United States Market (2016-2021)
6.2.5 Baxalta Recent Developments
6.3 Pfizer Inc
6.3.1 Pfizer Inc Company Details
6.3.2 Pfizer Inc Business Overview
6.3.3 Pfizer Inc Hemophilia Treatment Introduction
6.3.4 Pfizer Inc Hemophilia Treatment Revenue in United States Market (2016-2021)
6.3.5 Pfizer Inc Recent Developments
6.4 BioMarin
6.4.1 BioMarin Company Details
6.4.2 BioMarin Business Overview
6.4.3 BioMarin Hemophilia Treatment Introduction
6.4.4 BioMarin Hemophilia Treatment Revenue in United States Market (2016-2021)
6.4.5 BioMarin Recent Developments
6.5 Bayer Healthcare
6.5.1 Bayer Healthcare Company Details
6.5.2 Bayer Healthcare Business Overview
6.5.3 Bayer Healthcare Hemophilia Treatment Introduction
6.5.4 Bayer Healthcare Hemophilia Treatment Revenue in United States Market (2016-2021)
6.5.5 Bayer Healthcare Recent Developments
6.6 Biogen
6.6.1 Biogen Company Details
6.6.2 Biogen Business Overview
6.6.3 Biogen Hemophilia Treatment Introduction
6.6.4 Biogen Hemophilia Treatment Revenue in United States Market (2016-2021)
6.6.5 Biogen Recent Developments
6.7 Novo Nordisk
6.7.1 Novo Nordisk Company Details
6.7.2 Novo Nordisk Business Overview
6.7.3 Novo Nordisk Hemophilia Treatment Introduction
6.7.4 Novo Nordisk Hemophilia Treatment Revenue in United States Market (2016-2021)
6.7.5 Novo Nordisk Recent Developments
6.8 Roche
6.8.1 Roche Company Details
6.8.2 Roche Business Overview
6.8.3 Roche Hemophilia Treatment Introduction
6.8.4 Roche Hemophilia Treatment Revenue in United States Market (2016-2021)
6.8.5 Roche Recent Developments
6.9 Takeda
6.9.1 Takeda Company Details
6.9.2 Takeda Business Overview
6.9.3 Takeda Hemophilia Treatment Introduction
6.9.4 Takeda Hemophilia Treatment Revenue in United States Market (2016-2021)
6.9.5 Takeda Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of TablesTable 1. Hemophilia Treatment Market Opportunities & Trends in United States Market
Table 2. Hemophilia Treatment Market Drivers in United States Market
Table 3. Hemophilia Treatment Market Restraints in United States Market
Table 4. Key Players of Hemophilia Treatment in United States Market
Table 5. Top Hemophilia Treatment Players in United States Market, Ranking by Revenue (2019)
Table 6. United States Hemophilia Treatment Revenue by Companies, (US$, Mn), 2016-2021
Table 7. United States Hemophilia Treatment Revenue Share by Companies, 2016-2021
Table 8. Companies Hemophilia Treatment Product Type
Table 9. List of Tier 1 Hemophilia Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Hemophilia Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - United States Hemophilia Treatment Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - United States Hemophilia Treatment Revenue (US$, Mn), 2016-2021
Table 13. By Type - United States Hemophilia Treatment Revenue (US$, Mn), 2022-2027
Table 14. By Application - United States Hemophilia Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - United States Hemophilia Treatment Revenue (US$, Mn), 2016-2021
Table 16. By Application - United States Hemophilia Treatment Revenue (US$, Mn), 2022-2027
Table 17. CSL Behring Company Details
Table 18. CSL Behring Business Overview
Table 19. CSL Behring Hemophilia Treatment Product
Table 20. CSL Behring Hemophilia Treatment Revenue in United States Market (2016-2021) & (US$ Million)
Table 21. CSL Behring Recent Developments
Table 22. Baxalta Company Details
Table 23. Baxalta Business Overview
Table 24. Baxalta Hemophilia Treatment Product
Table 25. Baxalta Hemophilia Treatment Revenue in United States Market (2016-2021) & (US$ Million)
Table 26. Baxalta Recent Developments
Table 27. Pfizer Inc Company Details
Table 28. Pfizer Inc Business Overview
Table 29. Pfizer Inc Hemophilia Treatment Product
Table 30. Pfizer Inc Hemophilia Treatment Revenue in United States Market (2016-2021) & (US$ Million)
Table 31. Pfizer Inc Recent Developments
Table 32. BioMarin Company Details
Table 33. BioMarin Business Overview
Table 34. BioMarin Hemophilia Treatment Product
Table 35. BioMarin Hemophilia Treatment Revenue in United States Market (2016-2021) & (US$ Million)
Table 36. BioMarin Recent Developments
Table 37. Bayer Healthcare Company Details
Table 38. Bayer Healthcare Business Overview
Table 39. Bayer Healthcare Hemophilia Treatment Product
Table 40. Bayer Healthcare Hemophilia Treatment Revenue in United States Market (2016-2021) & (US$ Million)
Table 41. Bayer Healthcare Recent Developments
Table 42. Biogen Company Details
Table 43. Biogen Business Overview
Table 44. Biogen Hemophilia Treatment Product
Table 45. Biogen Hemophilia Treatment Revenue in United States Market (2016-2021) & (US$ Million)
Table 46. Biogen Recent Developments
Table 47. Novo Nordisk Company Details
Table 48. Novo Nordisk Business Overview
Table 49. Novo Nordisk Hemophilia Treatment Product
Table 50. Novo Nordisk Hemophilia Treatment Revenue in United States Market (2016-2021) & (US$ Million)
Table 51. Novo Nordisk Recent Developments
Table 52. Roche Company Details
Table 53. Roche Business Overview
Table 54. Roche Hemophilia Treatment Product
Table 55. Roche Hemophilia Treatment Revenue in United States Market (2016-2021) & (US$ Million)
Table 56. Roche Recent Developments
Table 57. Takeda Company Details
Table 58. Takeda Business Overview
Table 59. Takeda Hemophilia Treatment Product
Table 60. Takeda Hemophilia Treatment Revenue in United States Market (2016-2021) & (US$ Million)
Table 61. Takeda Recent Developments
List of FiguresFigure 1. Hemophilia Treatment Segment by Type
Figure 2. Hemophilia Treatment Segment by Application
Figure 3. United States Hemophilia Treatment Market Overview: 2020
Figure 4. United States Hemophilia Treatment Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. United States Hemophilia Treatment Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Hemophilia Treatment Revenue in 2020
Figure 7. By Type - United States Hemophilia Treatment Revenue Market Share, 2016-2027
Figure 8. By Application - United States Hemophilia Treatment Revenue Market Share, 2016-2027
Figure 9. CSL Behring Hemophilia Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. Baxalta Hemophilia Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Pfizer Inc Hemophilia Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. BioMarin Hemophilia Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. Bayer Healthcare Hemophilia Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. Biogen Hemophilia Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. Novo Nordisk Hemophilia Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. Roche Hemophilia Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 17. Takeda Hemophilia Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)